Advancing the Science of Radiopharmaceuticals
Conjugations
Radiolabeling
Research &
Development
Manufacturing
Advancing the
Science of Radiopharmaceuticals
Conjugations
Radiolabeling
Research &
Development
Manufacturing
100+
Years Combined
Experience
Your Partner -
Proposal to Product
IsoTherapeutics Group, LLC (IsoTherapeutics) is a radiopharmaceutical company that was founded in 2005 by two entrepreneur scientists with a passion for advancing the technology of radiopharmaceuticals. The company scientists, while employed at the Dow Chemical Company, developed QUADRAMET® a radiopharmaceutical for treatment of bone pain due to metastatic cancer, treatments for arthritis, osteoporosis, and osteomyelitis, just to name a few. IsoTherapeutics scientists have received over 100 patents for developing chemistry and radiopharmaceutical formulations.
IsoTherapeutics offers host of services to the pharmaceutical and life-science industries.
The range of services include helping customers/partners with early stage research from proof of concept for a new chemistry or drug molecule through making of the drug in a cGMP facility for preclinical studies. These services include:
- Radiopharmaceuticals
- Chelation
- Conjugation
-
Kit Development and
manufacturing
- Radiolabeling
- Analytical
- Small Animal Studies
-
Pharmacokinetics /
Bio-distribution
- Target processing
- Radiochemical processing
- Isotope Selection
- GLP and cGMP Manufacturing Services
Facilities
IsoTherapeutics Group is located about 45 miles south of Houston at 1004 South Velasco Street in Angleton, Texas. The facility consists of three buildings equipped with offices, R&D laboratories, cGMP production area, documentation room, shipping and receiving, controlled storage areas and an animal research laboratory.
